168 related articles for article (PubMed ID: 18056987)
1. Pharmacological stimulation of brain carnitine palmitoyl-transferase-1 decreases food intake and body weight.
Aja S; Landree LE; Kleman AM; Medghalchi SM; Vadlamudi A; McFadden JM; Aplasca A; Hyun J; Plummer E; Daniels K; Kemm M; Townsend CA; Thupari JN; Kuhajda FP; Moran TH; Ronnett GV
Am J Physiol Regul Integr Comp Physiol; 2008 Feb; 294(2):R352-61. PubMed ID: 18056987
[TBL] [Abstract][Full Text] [Related]
2. Fatty acid metabolism as a target for obesity treatment.
Ronnett GV; Kim EK; Landree LE; Tu Y
Physiol Behav; 2005 May; 85(1):25-35. PubMed ID: 15878185
[TBL] [Abstract][Full Text] [Related]
3. C75 increases peripheral energy utilization and fatty acid oxidation in diet-induced obesity.
Thupari JN; Landree LE; Ronnett GV; Kuhajda FP
Proc Natl Acad Sci U S A; 2002 Jul; 99(14):9498-502. PubMed ID: 12060712
[TBL] [Abstract][Full Text] [Related]
4. C75 is converted to C75-CoA in the hypothalamus, where it inhibits carnitine palmitoyltransferase 1 and decreases food intake and body weight.
Mera P; Bentebibel A; López-Viñas E; Cordente AG; Gurunathan C; Sebastián D; Vázquez I; Herrero L; Ariza X; Gómez-Puertas P; Asins G; Serra D; García J; Hegardt FG
Biochem Pharmacol; 2009 Mar; 77(6):1084-95. PubMed ID: 19094968
[TBL] [Abstract][Full Text] [Related]
5. The connections between C75 and obesity drug-target pathways.
Kuhajda FP; Landree LE; Ronnett GV
Trends Pharmacol Sci; 2005 Nov; 26(11):541-4. PubMed ID: 16169094
[TBL] [Abstract][Full Text] [Related]
6. Intraperitoneal injections of low doses of C75 elicit a behaviorally specific and vagal afferent-independent inhibition of eating in rats.
Mansouri A; Aja S; Moran TH; Ronnett G; Kuhajda FP; Arnold M; Geary N; Langhans W; Leonhardt M
Am J Physiol Regul Integr Comp Physiol; 2008 Sep; 295(3):R799-805. PubMed ID: 18667714
[TBL] [Abstract][Full Text] [Related]
7. Novel effect of C75 on carnitine palmitoyltransferase I activity and palmitate oxidation.
Bentebibel A; Sebastián D; Herrero L; López-Viñas E; Serra D; Asins G; Gómez-Puertas P; Hegardt FG
Biochemistry; 2006 Apr; 45(14):4339-50. PubMed ID: 16584169
[TBL] [Abstract][Full Text] [Related]
8. Important role of ventromedial hypothalamic carnitine palmitoyltransferase-1a in the control of food intake.
Gao S; Serra D; Keung W; Hegardt FG; Lopaschuk GD
Am J Physiol Endocrinol Metab; 2013 Aug; 305(3):E336-47. PubMed ID: 23736540
[TBL] [Abstract][Full Text] [Related]
9. Comparison of central and peripheral administration of C75 on food intake, body weight, and conditioned taste aversion.
Clegg DJ; Wortman MD; Benoit SC; McOsker CC; Seeley RJ
Diabetes; 2002 Nov; 51(11):3196-201. PubMed ID: 12401710
[TBL] [Abstract][Full Text] [Related]
10. C75, a fatty acid synthase inhibitor, modulates AMP-activated protein kinase to alter neuronal energy metabolism.
Landree LE; Hanlon AL; Strong DW; Rumbaugh G; Miller IM; Thupari JN; Connolly EC; Huganir RL; Richardson C; Witters LA; Kuhajda FP; Ronnett GV
J Biol Chem; 2004 Jan; 279(5):3817-27. PubMed ID: 14615481
[TBL] [Abstract][Full Text] [Related]
11. C75 alters central and peripheral gene expression to reduce food intake and increase energy expenditure.
Tu Y; Thupari JN; Kim EK; Pinn ML; Moran TH; Ronnett GV; Kuhajda FP
Endocrinology; 2005 Jan; 146(1):486-93. PubMed ID: 15498887
[TBL] [Abstract][Full Text] [Related]
12. Carnitine palmitoyltransferase-1 (CPT-1) activity stimulation by cerulenin via sympathetic nervous system activation overrides cerulenin's peripheral effect.
Jin YJ; Li SZ; Zhao ZS; An JJ; Kim RY; Kim YM; Baik JH; Lim SK
Endocrinology; 2004 Jul; 145(7):3197-204. PubMed ID: 15044358
[TBL] [Abstract][Full Text] [Related]
13. Chronic C75 treatment of diet-induced obese mice increases fat oxidation and reduces food intake to reduce adipose mass.
Thupari JN; Kim EK; Moran TH; Ronnett GV; Kuhajda FP
Am J Physiol Endocrinol Metab; 2004 Jul; 287(1):E97-E104. PubMed ID: 14736702
[TBL] [Abstract][Full Text] [Related]
14. Expression of FAS within hypothalamic neurons: a model for decreased food intake after C75 treatment.
Kim EK; Miller I; Landree LE; Borisy-Rudin FF; Brown P; Tihan T; Townsend CA; Witters LA; Moran TH; Kuhajda FP; Ronnett GV
Am J Physiol Endocrinol Metab; 2002 Nov; 283(5):E867-79. PubMed ID: 12376313
[TBL] [Abstract][Full Text] [Related]
15. Fatty acid metabolism in breast cancer cells: differential inhibitory effects of epigallocatechin gallate (EGCG) and C75.
Puig T; Vázquez-Martín A; Relat J; Pétriz J; Menéndez JA; Porta R; Casals G; Marrero PF; Haro D; Brunet J; Colomer R
Breast Cancer Res Treat; 2008 Jun; 109(3):471-9. PubMed ID: 17902053
[TBL] [Abstract][Full Text] [Related]
16. Fatty acid synthase inhibition triggers apoptosis during S phase in human cancer cells.
Zhou W; Simpson PJ; McFadden JM; Townsend CA; Medghalchi SM; Vadlamudi A; Pinn ML; Ronnett GV; Kuhajda FP
Cancer Res; 2003 Nov; 63(21):7330-7. PubMed ID: 14612531
[TBL] [Abstract][Full Text] [Related]
17. Fatty acid oxidation and meiotic resumption in mouse oocytes.
Downs SM; Mosey JL; Klinger J
Mol Reprod Dev; 2009 Sep; 76(9):844-53. PubMed ID: 19455666
[TBL] [Abstract][Full Text] [Related]
18. The anorexigenic fatty acid synthase inhibitor, C75, is a nonspecific neuronal activator.
Takahashi KA; Smart JL; Liu H; Cone RD
Endocrinology; 2004 Jan; 145(1):184-93. PubMed ID: 14512433
[TBL] [Abstract][Full Text] [Related]
19. Fatty acid metabolism, the central nervous system, and feeding.
Ronnett GV; Kleman AM; Kim EK; Landree LE; Tu Y
Obesity (Silver Spring); 2006 Aug; 14 Suppl 5():201S-207S. PubMed ID: 17021367
[TBL] [Abstract][Full Text] [Related]
20. Important roles of brain-specific carnitine palmitoyltransferase and ceramide metabolism in leptin hypothalamic control of feeding.
Gao S; Zhu G; Gao X; Wu D; Carrasco P; Casals N; Hegardt FG; Moran TH; Lopaschuk GD
Proc Natl Acad Sci U S A; 2011 Jun; 108(23):9691-6. PubMed ID: 21593415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
